Allworth Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
563
+520
+1,209% +$10.5K ﹤0.01% 3628
2026
Q1
$843 Sell
43
-1,443
-97% -$35.3K ﹤0.01% 4618
2025
Q4
$39.8K Buy
1,486
+11
+0.7% +$283 ﹤0.01% 2343
2025
Q3
$39.3K Sell
1,475
-70
-5% -$1.81K ﹤0.01% 2269
2025
Q2
$35.5K Sell
1,545
-21
-1% -$521 ﹤0.01% 2158
2025
Q1
$37.7K Buy
1,566
+140
+10% +$4.47K ﹤0.01% 1696
2024
Q4
$51.5K Hold
1,426
– – ﹤0.01% 1560
2024
Q3
$69.2K Hold
1,426
– – ﹤0.01% 1250
2024
Q2
$56.5K Hold
1,426
– – ﹤0.01% 1326
2024
Q1
$62.6K Sell
1,426
-44
-3% -$2.27K ﹤0.01% 1212
2023
Q4
$90.9K Buy
1,470
+41
+3% +$2.15K ﹤0.01% 980
2023
Q3
$65.7K Buy
1,429
+15
+1% +$818 ﹤0.01% 1029
2023
Q2
$81.3K Hold
1,414
– – ﹤0.01% 963
2023
Q1
$53K Buy
1,414
+31
+2% +$1.02K ﹤0.01% 1050
2022
Q4
$38.8K Sell
1,383
-490
-26% -$14.2K ﹤0.01% 1111
2022
Q3
$53K Buy
1,873
+26
+1% +$849 ﹤0.01% 938
2022
Q2
$64K Hold
1,847
– – ﹤0.01% 826
2022
Q1
$66K Buy
1,847
+57
+3% +$1.62K ﹤0.01% 818
2021
Q4
$42K Buy
+1,790
New +$36.6K ﹤0.01% 887

Other funds holding AMPH

Allworth Financial's AMPH Position: Q2 2026 in Review

Allworth Financial increased its Amphastar Pharmaceuticals (AMPH) stake by 1,209% in Q2 2026, buying an estimated $10.5K and bringing the position to 563 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Allworth Financial first reported a position in AMPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $90.9K in Q4 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Allworth Financial held 563 shares of Amphastar Pharmaceuticals worth $11.4K as of Q2 2026.
  • Allworth Financial bought 520 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $10.5K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3628 holding.
  • Allworth Financial first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allworth Financial's Amphastar Pharmaceuticals position peaked at $90.9K in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.